BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6290020)

  • 1. Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Cancer; 1982 Nov; 50(10):2024-7. PubMed ID: 6290020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
    Berkowitz RS; Goldstein DP
    Obstet Gynecol; 1979 Dec; 54(6):725-8. PubMed ID: 229448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate with citrovorum factor rescue: reduced chemotherapy toxicity in the management of gestational trophoblastic neoplasms.
    Berkowitz RS; Goldstein DP; Jones MA; Marean AR; Bernstein MR
    Cancer; 1980 Feb; 45(3):423-6. PubMed ID: 6243507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1984 Oct; 19(2):173-81. PubMed ID: 6208089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate with citrovorum factor rescue for gestational trophoblastic neoplasms.
    Goldstein DP; Saracco P; Osathanondh R; Goldstein PR; Marean AR; Bernstein MR
    Obstet Gynecol; 1978 Jan; 51(1):93-6. PubMed ID: 201893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate with citrovorum factor in low-risk gestational trophoblastic tumor.
    Bolis G; Colombo N; Epis A; Mangili G; Vassena L; Vergadoro F; Belloni C
    Tumori; 1987 Jun; 73(3):309-13. PubMed ID: 3037744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
    McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
    J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1986 Jan; 23(1):111-8. PubMed ID: 3002916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
    Matsui H; Iitsuka Y; Seki K; Sekiya S
    Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
    Goldstein DP; Goldstein PR; Bottomley P; Osathanondh R; Marean AR
    Obstet Gynecol; 1976 Sep; 48(3):321-3. PubMed ID: 181702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Am J Obstet Gynecol; 1985 May; 152(1):59-62. PubMed ID: 2986458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmetastatic and low-risk metastatic gestational trophoblastic neoplasms.
    Goldstein DP; Berkowitz RS
    Semin Oncol; 1982 Jun; 9(2):191-7. PubMed ID: 6289462
    [No Abstract]   [Full Text] [Related]  

  • 13. Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1990 Jan; 36(1):56-9. PubMed ID: 2153091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose methotrexate for gestational trophoblastic disease.
    Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
    Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate--folinic acid.
    Smith EB; Weed JC; Tyrey L; Hammond CB
    Am J Obstet Gynecol; 1982 Sep; 144(1):88-92. PubMed ID: 6287843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High risk malignant gestational trophoblastic disease: experience with triple chemotherapy (MAC) in Third World circumstances.
    du Toit JP
    Gynecol Oncol; 1989 Mar; 32(3):310-3. PubMed ID: 2465940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.
    Gleeson NC; Finan MA; Fiorica JV; Robert WS; Hoffman MS; Wilson J
    Eur J Gynaecol Oncol; 1993; 14(6):461-5. PubMed ID: 7514124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
    Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trophoblastic cell sensitivity to 8-day chemotherapy in nonmetastatic gestational trophoblastic neoplasia.
    Hilgers RD; Standefer JC; Rutledge JM; Ampuero F
    Gynecol Oncol; 1984 Mar; 17(3):386-93. PubMed ID: 6200387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.
    Roberts JP; Lurain JR
    Am J Obstet Gynecol; 1996 Jun; 174(6):1917-23; discussion 1923-4. PubMed ID: 8678159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.